Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Ethnopharmacol ; 112(2): 327-32, 2007 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-17451897

RESUMO

In the present studies, the effect of paeoniflorin (PF), one of the main compounds extracted from Paeoniae radix, in alleviating the neurological impairment following unilateral striatal 6-hydroxydopamine (6-OHDA) lesion was examined in Sprague-Dawley rats. Sub-chronic PF (2.5, 5 and 10 mg/kg, s.c., twice daily for 11 days) administration dose-dependently reduced apomorphine (APO)-induced rotation, suggesting that PF had an ameliorative effect on the 6-OHDA-induced neurological impairment. Notably, PF had no direct action on dopamine D(1) receptor or dopamine D(2) receptor indicated by the competitive binding experiments. These results suggest that PF, an active component of Paeoniae radix, might provide an opportunity to introduce a non-dopaminergic management of Parkinson's disease.


Assuntos
Comportamento Animal/efeitos dos fármacos , Benzoatos/farmacologia , Hidrocarbonetos Aromáticos com Pontes/farmacologia , Glucosídeos/farmacologia , Doença de Parkinson Secundária/tratamento farmacológico , Doença de Parkinson Secundária/psicologia , Animais , Apomorfina/farmacologia , Benzazepinas/metabolismo , Benzoatos/administração & dosagem , Benzoatos/química , Ligação Competitiva/efeitos dos fármacos , Hidrocarbonetos Aromáticos com Pontes/administração & dosagem , Hidrocarbonetos Aromáticos com Pontes/química , Agonistas de Dopamina/farmacologia , Antagonistas de Dopamina/metabolismo , Glucosídeos/administração & dosagem , Glucosídeos/química , Hidroxidopaminas , Técnicas In Vitro , Masculino , Membranas/efeitos dos fármacos , Membranas/metabolismo , Microinjeções , Monoterpenos , Neostriado/efeitos dos fármacos , Neostriado/metabolismo , Doença de Parkinson Secundária/induzido quimicamente , Racloprida/metabolismo , Ratos , Ratos Sprague-Dawley , Comportamento Estereotipado/efeitos dos fármacos
2.
Eur J Pharmacol ; 549(1-3): 166-72, 2006 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-16989810

RESUMO

Cyclooxygenase-2 (COX-2) is a key enzyme that catalyzes the biosynthesis of prostaglandins from arachidonic acid and plays a critical role in some pathologies including inflammation, neurodegenerative diseases and cancer. Cryptotanshinone is a major constituent of tanshinones, which are extracted from the medicinal herb Salvia miltiorrhiza Bunge, and has well-documented antioxidative and anti-inflammatory effects. This study confirmed the remarkable anti-inflammatory effect of cryptotanshinone in the carrageenan-induced rat paw edema model. Since the action of cryptotanshinone on COX-2 has not been previously described, in the present study, we further examined the effect of cryptotanshinone on cyclooxygenase activity in the exogenous arachidonic acid-stimulated insect sf-9 cells, which highly express human COX-2 or human COX-1, and on cyclooxygenases expression in human U937 promonocytes stimulated by lipopolysaccharide (LPS) plus phorbolmyristate acetate (PMA). Cryptotanshinone reduced prostaglandin E2 synthesis and reactive oxygen species generation catalyzed by COX-2, without influencing COX-1 activity in cloned sf-9 cells. In PMA plus LPS-stimulated U937 cells, cryptotanshinone had negligible effects on the expression of COX-1 and COX-2, at either a mRNA or protein level. These results demonstrate that the anti-inflammatory effect of cryptotanshinone is directed against enzymatic activity of COX-2, not against the transcription or translation of the enzyme.


Assuntos
Anti-Inflamatórios/farmacologia , Inibidores de Ciclo-Oxigenase 2/farmacologia , Ciclo-Oxigenase 2/metabolismo , Fenantrenos/farmacologia , Animais , Ácido Araquidônico/farmacologia , Western Blotting , Carragenina , Linhagem Celular , Ciclo-Oxigenase 1/genética , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/genética , Dinoprostona/metabolismo , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas , Edema/induzido quimicamente , Edema/prevenção & controle , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Membro Posterior/efeitos dos fármacos , Membro Posterior/patologia , Humanos , Estrutura Molecular , Fenantrenos/química , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Salvia/química , Spodoptera , Células U937
3.
J Pharmacol Exp Ther ; 319(1): 165-80, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16840647

RESUMO

Paeoniflorin (PF) is the principal component of Paeoniae radix prescribed in traditional Chinese medicine. The delayed neuroprotection induced by PF preconditioning and its underlying mechanisms were investigated in rat middle cerebral artery occlusion (MCAO) and reperfusion model. At a dosage of 20 or 40 mg/kg, PF preconditioning 48 h before MCAO followed by 24-h reperfusion significantly reduced the mortality and infarct volume and reversed the neurological deficits caused by ischemia. Likewise, the ameliorative effects on mortality, infarct size, and neurological impairment induced by MCAO emerged as well when PF was administered 24 h, 48 h, or 5 days before MCAO at the dose of 20 mg/kg. Furthermore, comparative proteomics analysis was adopted to identify the differentially expressed proteins induced by PF preconditioning itself. The relative levels of 42 proteins were altered after PF preconditioning, among which 20 were elevated and 22 reduced. In summary, A(1) receptor-regulator of G protein signaling-K(ATP) signaling, arachidonic acid cascade, nitric oxide system, markers of neuronal damage, mitochondrial damage-related molecules, and the mitogen-activated protein kinase and nuclear factor-kappaB pathway are associated with the mechanisms of PF preconditioning.


Assuntos
Benzoatos/farmacologia , Hidrocarbonetos Aromáticos com Pontes/farmacologia , Glucosídeos/farmacologia , Precondicionamento Isquêmico , Fármacos Neuroprotetores/farmacologia , Trifosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Animais , Ácido Araquidônico/metabolismo , Fator Neurotrófico Derivado do Encéfalo/fisiologia , Proteínas de Choque Térmico HSP70/fisiologia , Sistema de Sinalização das MAP Quinases , Masculino , Dados de Sequência Molecular , Monoterpenos , NF-kappa B/fisiologia , Naloxona/farmacologia , Canais de Potássio/fisiologia , Proteínas RGS/fisiologia , Ratos , Ratos Sprague-Dawley , Receptor A1 de Adenosina/fisiologia
4.
Planta Med ; 72(7): 590-5, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16636966

RESUMO

Three new lignan derivatives, conicaols A and B and conicaoside, together with seven known compounds were identified from Saussurea conica. Their structures were elucidated by spectral methods including 1D and 2D NMR techniques. Six 2,3-dibenzylbutyrolactone-type lignans were biologically evaluated, and two of them, arctigenin and matairesinol, showed potent activity to suppress NO production in vitro in LPS-activated macrophages of SD rat.


Assuntos
Lignanas/isolamento & purificação , Lignanas/farmacologia , Óxido Nítrico/antagonistas & inibidores , Saussurea/química , Lignanas/química , Estrutura Molecular
5.
Life Sci ; 78(16): 1839-44, 2006 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-16289139

RESUMO

Ketamine is a racemic mixture containing equal parts of (+)-ketamine and (-)-ketamine. The ketamine enantiomorphs are different in anesthesia and psychic emergence reactions after anesthesia. Therefore, (+)-ketamine was compared with racemic ketamine in a number of randomized studies in volunteers and patients. However, their relations remain controversial. In the present studies, the psychic emergence reactions after injection of (+/-)-ketamine and (+)-ketamine were compared in mice. At equimolar doses, the (+)-isomers elicited episodes of hypnosis nearly 1.4-fold more potent than those of the racemic ketamine. After the administration of equihypnotic doses of (+)-ketamine and (+/-)-ketamine, the posthypnotic stimulation of locomotor activity, stereotype behavior and 5-HT-induced head-twitch response by the (+)-enantiomorph was significantly less intense than that of racemic ketamine. In receptor binding test, (+)-ketamine showed a higher affinity for NMDA receptor than that of (+/-)-ketamine, while (+)-ketamine and (+/-)-ketamine showed no affinity for dopamine D2 and serotonin 5-HT2 receptor. These results suggest that the (+)-ketamine has fewer posthypnotic side effects than (+/-)-ketamine when (+)-ketamine and (+/-)-ketamine were administered at equihypnotic dosages and that dopamine D2 and serotonin 5-HT2 receptor were not involved in the effects of (+)-ketamine and (+/-)-ketamine.


Assuntos
Anestésicos Dissociativos/farmacologia , Comportamento Animal/efeitos dos fármacos , Ketamina/farmacologia , Atividade Motora/efeitos dos fármacos , Reflexo Abdominal/efeitos dos fármacos , Comportamento Estereotipado/efeitos dos fármacos , Animais , Hipnose , Masculino , Camundongos , Ratos , Ratos Wistar , Receptores de Dopamina D2/metabolismo , Receptores 5-HT2 de Serotonina/metabolismo , Estereoisomerismo
6.
Life Sci ; 78(4): 413-20, 2005 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-16137717

RESUMO

In the present study, the effects of paeoniflorin (PF), a characteristic monoterpene glucoside isolated from Paeoniae Radix, on cerebral infarction, neurological symptoms, tongue protrusion (TP) and performance in the water maze were examined at the chronic stage (4 weeks) of transient cerebral ischemia using a rat middle cerebral artery occlusion (MCAO) model. One-day (10 mg/kg, twice, s.c.) or seven-day (2.5-10 mg/kg, twice a day, s.c.) injection of PF significantly reduced the infarct volume as well as ameliorated the deficits in neurological symptoms caused by transient MCAO at chronic stage. Transient MCAO also induced impairments in TP and performance in the water maze. Treatment with PF was able to reverse or alleviate these impairments. These results indicate that PF may be effective for treatment of stroke.


Assuntos
Comportamento Animal/efeitos dos fármacos , Benzoatos/uso terapêutico , Hidrocarbonetos Aromáticos com Pontes/uso terapêutico , Transtornos Cognitivos/tratamento farmacológico , Cognição/efeitos dos fármacos , Glucosídeos/uso terapêutico , Infarto da Artéria Cerebral Média/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Paeonia/química , Animais , Arteriopatias Oclusivas , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Infarto da Artéria Cerebral Média/patologia , Infarto da Artéria Cerebral Média/fisiopatologia , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Monoterpenos , Extratos Vegetais/uso terapêutico , Ratos , Ratos Sprague-Dawley , Recuperação de Função Fisiológica , Natação
7.
Eur J Pharmacol ; 500(1-3): 221-30, 2004 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-15464035

RESUMO

Natural products have been used as medicinal agents for many years. In addition, these compounds have also served as the starting points for semisynthetic analogs with improved properties. This review focuses on recent advances in the pharmacological studies on natural products mainly performed and published in China. Emphasis will be placed on those compounds that show the greatest promise clinically such as huperzine A (9-amino-13-ethylidene-11-methyl-4-azatricyclo[7.3.1.0(3.8)]trideca-3(8),6,11-trien-5-one), s-(-)-3-n-butylphthalide (s-(-)-3-butyl-1(3H)-isobenzofuranone), (-)-clausenamide (3-hydroxy-4-phenyl-5a-hydroxybenzyl-N-methyl-gamma-lactam) and Ginkgo biloba extract and its active components.


Assuntos
Berberina/análogos & derivados , Medicamentos de Ervas Chinesas/farmacologia , Alcaloides , Animais , Benzofuranos/química , Benzofuranos/farmacologia , Berberina/química , Berberina/farmacologia , China , Inibidores da Colinesterase/química , Inibidores da Colinesterase/farmacologia , Diterpenos/química , Diterpenos/farmacologia , Agonistas de Dopamina/química , Agonistas de Dopamina/farmacologia , Antagonistas de Dopamina/química , Antagonistas de Dopamina/farmacologia , Compostos de Epóxi , Ginkgo biloba/química , Humanos , Imunossupressores/química , Imunossupressores/farmacologia , Lactamas/química , Lactamas/farmacologia , Lignanas/química , Lignanas/farmacologia , Fármacos Neuroprotetores/química , Fármacos Neuroprotetores/farmacologia , Fenantrenos/química , Fenantrenos/farmacologia , Rutaceae/química , Sesquiterpenos/química , Sesquiterpenos/farmacologia
8.
Mem. Inst. Oswaldo Cruz ; 86(suppl. 2, n.esp): 173-5, Oct. 1991.
Artigo em Inglês | LILACS | ID: lil-127850

RESUMO

We have recenty studied several natural product constituents which have effects on the CNS. (1) Tetrahydropalmatine (THP) and its analogues were isolated from Corydalis ambigua and various species of Stephania. (+)-THP and (-_-THP posses not only analgesic activity, but also exert sedative-tranquillizing and hypnotic actions. Results of receptor binding assay and their pre-and post-synaptic effects on dopaminergic system indicate that (-)-THP and (-)-stepholidine are dopamine receptor antagonists while (+)-THP is a selective dopamine depletor. (2) 3-Acetylaconitine (AAC) is an alkaloid isolated from Aconitum flavum. The relative potency of analgesic action of AAC was 5.1-35.6 and 1250-3912 times that of morphine and aspirin, respectively. The analgesic effect of AAC was antagonized by naloxone, but was eliminated by reserpine. In monkeys, after AAC was injected for 92 days, no abstinence syndrome was seen after sudden AAC withdrawal or when challenged with nalorphine. (3) Huperzine A (Hup-A) is an alkaloid isolated from Huperzia serrata which was found to be a selective ChE inhibitor and could improve learning and retrieval process. Preliminary clinical studies showed that Hup-A improve short-and long-term memory in patients of cerebral arteriosclerosis with memory impairment. (4) Ranamargarin is a new tetradecapeptide isolated from the skin of the Chines frog Rana margaratae. This peptide may mainly act on NK-1 receptor


Assuntos
Humanos , Animais , Fármacos do Sistema Nervoso Central/farmacologia , Depressores do Sistema Nervoso Central/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Sequência de Aminoácidos , Dados de Sequência Molecular , Avaliação Pré-Clínica de Medicamentos , Transtornos da Memória/tratamento farmacológico
9.
Mem. Inst. Oswaldo Cruz ; 86(supl.2): 173-175, 1991.
Artigo em Inglês | LILACS | ID: lil-623964

RESUMO

We have recenty studied several natural product constituents which have effects on the CNS. (1) Tetrahydropalmatine (THP) and its analogues were isolated from Corydalis ambigua and various species of Stephania. (+)-THP and (-)-THP posses not only analgesic activity, but also exert sedative-tranquillizing and hypnotic actions. Results of receptor binding assay and their pre-and post-synaptic effects on dopaminergic system indicate that (-)-THP and (-)-stepholidine are dopamine receptor antagonists while (+)-THP is a selective dopamine depletor. (2) 3-Acetylaconitine (AAC) is an alkaloid isolated from Aconitum flavum. The relative potency of analgesic action of AAC was 5.1-35.6 and 1250-3912 times that of morphine and aspirin, respectively. The analgesic effect of AAC was antagonized by naloxone, but was eliminated by reserpine. In monkeys, after AAC was injected for 92 days, no abstinence syndrome was seen after sudden AAC withdrawal or when challenged with nalorphine. (3) Huperzine A (Hup-A) is an alkaloid isolated from Huperzia serrata which was found to be a selective ChE inhibitor and could improve learning and retrieval process. Preliminary clinical studies showed that Hup-A improve short-and long-term memory in patients of cerebral arteriosclerosis with memory impairment. (4) Ranamargarin is a new tetradecapeptide isolated from the skin of the Chines frog Rana margaratae. This peptide may mainly act on NK-1 receptor.


Assuntos
Humanos , Animais , Medicamentos de Ervas Chinesas/farmacologia , Depressores do Sistema Nervoso Central/farmacologia , Fármacos do Sistema Nervoso Central/farmacologia , Transtornos da Memória/tratamento farmacológico , Dados de Sequência Molecular , Sequência de Aminoácidos , Avaliação de Medicamentos , Avaliação Pré-Clínica de Medicamentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA